Co-administered gabapentin and venlafaxine in nerve injured rats: Effect on mechanical hypersensitivity, motor function and pharmacokinetics

Scandinavian Journal of Pain

Volumn 1, Issue 2, 2010, Pages 91-97

  Folkesson, Anna ^a   Honoré, Per Hartvig ^a   Bjerrum, Ole J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Combination pharmacotherapy; Gabapentin; Neuropathic pain; Pharmacokinetics; Spared nerve injury model; Venlafaxine

Indexed keywords

GABAPENTIN; VENLAFAXINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; HYPERSENSITIVITY; MALE; MOTOR PERFORMANCE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PERONEUS NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SOMNOLENCE; SURAL NERVE; TIBIAL NERVE; TREATMENT OUTCOME;

EID: 77649331029     PISSN: 18778860     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjpain.2009.12.001     Document Type: Article

References (35)

1. Harden N., and Cohen M. Unmet needs in the management of neuropathic pain. J Pain Symptom Manage 25 (2003) S12-S17
2. Gilron I., Watson C.P., Cahill C.M., and Moulin D.E. Neuropathic pain: a practical guide for the clinician. CMAJ 175 (2006) 265-275
3. Meyer-Rosberg K., Kvarnstrom A., Kinnman E., Gordh T., Nordfors L.O., and Kristofferson A. Peripheral neuropathic pain-a multidimensional burden for patients. Eur J Pain 5 (2001) 379-389
4. Jensen M.P., Chodroff M.J., and Dworkin R.H. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 68 (2007) 1178-1182
5. Attal N., Cruccu G., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T., Sampaio C., Sindrup S., and Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
6. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., Kalso E.A., Loeser J.D., Miaskowski C., Nurmikko T.J., Portenoy R.K., Rice A.S.C., Stacey B.R., Treede R.D., Turk D.C., and Wallace M.S. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 (2007) 237-251
7. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., and Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280 (1998) 1831-1836
8. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
9. Gordh T.E., Stubhaug A., Jensen T.S., Arnèr S., Biber B., Boivie J., Mannheimer C., Kalliomaki J., and Kalso E. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 138 (2008) 255-266
10. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol 20 (2007) 456-472
11. Gilron I., and Max M.B. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Exp Rev Neurother 5 (2005) 823-830
12. Sutton K.G., Martin D.J., Pinnock R.D., Lee K., and Scott R.H. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 135 (2002) 257-265
13. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C.I., and Myers R.R. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303 (2002) 1199-1205
14. Tanabe M., Takasu K., Kasuya N., Shimizu S., Honda M., and Ono H. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br J Pharmacol 144 (2005) 703-714
15. Tanabe M., Takasu K., Takeuchi Y., and Ono H. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 86 (2008) 3258-3264
16. Takasu K., Honda M., Ono H., and Tanabe M. Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury. Br J Pharmacol 148 (2006) 233-244
17. Takeuchi Y., Takasu K., Honda M., Ono H., and Tanabe M. Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury. Eur J Pharmacol 556 (2007) 69-74
18. Hayashida K., DeGoes S., Curry R., and Eisenach J.C. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106 (2007) 557-562
19. Hayashida K., Obata H., Nakajima K., and Eisenach J.C. Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 109 (2008) 1077-1084
20. Holliday S.M., and Benfield P. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs 49 (1995) 280-294
21. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
22. Decosterd I., and Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87 (2000) 149-158
23. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J.M., and van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21 (2001) 15-23
24. Hengy H., and Kolle E.U. Determination of gabapentin in plasma and urine by high-performance liquid chromatography and pre-column labelling for ultraviolet detection. J Chromatogr 341 (1985) 473-478
25. Tallarida R.J. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 319 (2006) 1-7
26. Hayashida K., and Eisenach J.C. Multiplicative interactions to enhance gabapentin to treat neuropathic pain. Eur J Pharmacol 598 (2008) 21-26
27. Eroglu C., Allen N.J., Susman M.W., O'Rourke N.A., Park C.Y., Özkan E., Chakraborty C., Mulinyawe S.B., Annis D.S., Huberman A.D., Green E.M., Lawler J., Dolmetsch R., Garcia K.C., Smith S.J., Luo Z.D., Rosenthal A., Mosher D.F., and Barres B.A. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139 (2009) 380-392
28. Hao J.X., Xu X.J., Urban L., and Wiesenfeld-Hallin Z. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neurosci Lett 280 (2000) 211-214
29. Vollmer K.O., von H.A., and Kolle E.U. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 36 (1986) 830-839
30. Rode F., Brolos T., Blackburn-Munro G., and Bjerrum O.J. Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain. Psychopharmacology (Berl) 187 (2006) 364-375
31. Suzuki R., Rygh L.J., and Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25 (2004) 613-617
32. Suzuki R., Rahman W., Rygh L.J., Webber M., Hunt S.P., and Dickenson A.H. Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain 117 (2005) 292-303
33. Rahman W., Suzuki R., Webber M., Hunt S.P., and Dickenson A.H. Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain 123 (2006) 264-274
34. Simpson D.A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 3 (2001) 53-62
35. Gilron I., Bailey J.M., Tu D., Holden R.R., Jackson A.C., and Houlden R.L. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet (2009)